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Exon amplification is a method used to identify regions of DNA that contain
transcribed sequences. The large cloning capacity of yeast artificial chromosome (YAC)
systems and the inability to isolate large intact DNA from YACs introduce limitations to
the exon amplification technique. The feasibility of exon amplification from a mega-
YAC clone 2001C6 (CEPH) has been analyzed as a means to isolate transcribed
sequences and has been used to produce 10 putative exon sequences from human
chromosome 17q21. Six of the sequences showed homology to sequences that were
previously published in the GenBANK database. Three of the sequences showed no
homology, thereby indicating the isolation of putatively novel sequences. The sequences
were radiolabeled and used as hybridization probes on a multiple tissue RNA dot blot.
This blot contains RNA isolated from 50 human tissues. Clone E5 produced
hybridization signals in fetal liver, fetal spleen and placenta. Clone F12 produced
hybridization signals in fetal liver, fetal spleen, placenta and bone marrow. Clone G12
produced hybridization signals in all of the RNAs, indicating a pattern of expression
similar to that of a housekeeping gene. These findings contribute to the enhancement of a
high density transcriptional map within the q21-q22 region of human chromosome 17.
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The human genome is a complex genome of approximately three billion base
pairs. It consists of coding sequences, exons, which produce mature RNA and/or
functional polypeptides and noncoding sequences (introns). The expression of the coding
sequences determine all phenotypic and genotypic traits possessed by man. Currently,
there are more than three thousand known genetic diseases that affect the lives of many
people. Therefore, it is extremely important to characterize these genes in order to
address myriad genetic related issues that currently face the human population. The
initial step in gene identification and characterization is to ascertain the identity of every
gene sequence at the level of the nucleotide base. This tremendous task has been taken
on by a collaborative international effort called the Human Genome Project (HGP).
The Human Genome Project began in 1986 as the Human Genome Initiative
sponsored by the U. S. Department of Energy (DOE). In 1988, the National Research
Council allocated a budget of $200 million/year for fifteen years specifically dedicated to
genome research. Along with the DOE, funds were appropriated to the National
Institutes of Health (NIH) to support research relevant to sequencing and understanding
the human genome. From the NIH participation, the National Center for Human Genome
Research (NCHGR) was developed. In 1997, NCHGR became the National Human
Genome Research Institute (NHGRI). NHGRI not only oversees human genome
research in the United States, but it also plays an active role in researching the legal,
social, and ethical effects of genome research.
The primary goal of the Human Genome Project is to obtain the nucleotide
sequence of every gene present in the 24 chromosomes in the human genome (Barnhart et
al, 1989; HGP, 1992). The ultimate goal of the Human Genome Project is to provide a
means by which preventive and therapeutic measures may be used to treat people with
genetic diseases and disorders, and to identify disease genes at or before the fetal stages
of development (HGP, 1992).
There are many facets to attaining the goals of this enormous project. The search
for disease genes is a multi-step process. First, gene localization must occur through
physical and transcriptional mapping of the genome. Then, isolation and alignment of
transcripts are carried out which ultimately lead to gene identification. Several
approaches may be used to isolate transcriptionally active sequences. These include exon
amplification (Buckler et al, 1991), exon trapping (Duyk et al, 1990), direct DNA
selection (Parimoo et al, 1991; Lovett et al, 1991), direct screening (Wallace et al,
1990), CpG island based methods (Bird, 1986; Patel et al, 1991; Valdes et al, 1994) and
genomic sequencing (Oliver et al, 1992; Sulston etal, 1992).
There are regions on every chromosome, which are gene dense, containing many
clusters of genes, as well as regions where genes are sparse. This fact is demonstrated by
G-banding, which distinguishes the two. The G-banding patterns indicate that the q21
region of human chromosome 17 has a high G-C content which is an indication of a gene
dense region (Strachan and Read, 1995).
Chromosome 17 has been selected as an excellent candidate for yeast artificial
chromosome (YAC) based transcriptional mapping because of its gene dense regions. It
is a relatively small chromosome of 80-95 Mb. Several genes have been localized to
human chromosome 17q including BRCA1 and neurofibromatosis. Because of these
characteristics, several Genome Centers have geared their research toward sequencing
this chromosome. As an independent laboratory, the Human Genome Laboratory at
Clark Atlanta University has made chromosome 17 the center of its sequencing efforts.
A. Broad Objective
The focus of this research is to isolate novel transcriptionally active sequences
from a cloned 1.7 megabase region of human chromosome 17q21.
B. Specific Aims
1. To define and optimize conditions for the isolation of mega-YAC clone
2001C6.
2. To isolate expressed sequences from human chromosome 17q21.
3. To identify expressed sequences as known or novel sequences.
CHAPTER 2
LITERATURE REVIEW
For many years, yeast has proven to be a phenomenal organism for brewing and
baking. The microorganism was first introduced into the genetics laboratory by
Winge et al. in the 1930's as the strain Saccharomyces cerevisiae. Since then, S.
cerevisiae has become a commonly used organism for geneticists (Scott, 1982). Yeast
have been used as hosts for both cloning and expression vectors. Cloning vectors in the
form of artificial chromosomes were constructed specifically for use in yeast in the form
of a yeast artificial chromosome (YAC).
2.1 The Yeast Artificial Chromosome Vector
2.1.1 Structural Characteristics
David Burke, a graduate student in Maynard Olson's group at Washington
University in St. Louis, developed the first functional YAC system (Burke et al., 1987).
Before this point, several cloning vectors were already available, however their use was
very limited because of their small cloning capacity. Cosmids have a cloning capacity of
35-45 kb (Meyerowitz et al., 1980, Collins et al, 1977, 1978), bacterial artificial
chromosomes (BAC) up to 300 kb (Shizuya et al, 1992), bacteriophage PI up to 90 kb
(Sternberg, 1990), and PI-derived artificial chromosomes (PAC) up to 300 kb (Ioannou
et al, 1994). Although these systems are very useful, their limited cloning capacity
makes it extremely difficult to cover a large region of a genome without having to handle
a large quantity of clones at one time. The advent of the YAC greatly enhanced vector
cloning capability. It allowed cloning of up to 2 Mb of exogenous DNA which could
then be placed into a yeast strain and propagated without any disruption of the yeast cell.
The structural characteristics of the YAC vector (Jordan, 1990) and scheme for cloning
exogenous DNA into the YAC (Burke, 1991) are shown in Fig. 1 and Fig. 2, respectively.
The original YAC vectors were derived from the pBR322 vector and contain certain
essential elements:
1. SUP4 gene—a selectable marker contained in the cloning site that gives a red
phenotypic appearance when disrupted by insert DNA (Burke et ah, 1987).
2. Autonomously Replicating Sequence (ARS)—contains the origin of replication
(Struhl et al, 1979).
3. Centromere (CEN4)--origin of the mitotic spindle; site from which
microtubles form and project to allow meiotic and mitotic cell division
(Clarke etal, 1980).
4. Selectable markers TRP1 and URA3, one on each side of the telomere, contain
sequences that encode enzymes for de novo synthesis of tryptophan and uracil.






Figure 1. Diagram of YAC Vector. (Jordan, 1990)
Total genomic DNA or sorted chromosomes
Fragment DNA by restriction digestion
Size DNA fragments by electrophoresis






Figure 2. Cloning of exogenous DNA into a YAC. (modified from Burke, 1991)
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The circular plasmid is made linear by restriction digestion to yield three
segments: a left arm, a right arm, and a stuffer region. The restriction digestion disrupts
the SUP4 gene, which contains the EcoRI cloning site, leaving cohesive ends for ligation
for the exogenous DNA to be cloned into the now linear vector. When the YAC vector
was introduced, molecular geneticists were excited by the idea that up to 2 Mb of DNA
could be cloned into one vector. Once YAC systems became available, a group of
French scientists at Centre d'Etude du Polymorphisme Humain (CEPH) (Paris, France)
immediately began to clone megabase regions of the human genome to make a mega-
YAC library. A copy of this library was then sent to scientists at the Massachusetts
Institute of Technology's Whitehead Institute who made, replicated and distributed them
to several other Genome Centers (Anderson, 1993).
2.1.2. Problems with YACs
Although YACs proved to be useful, as with any cloning system, they also had
several flaws. Low efficiency of transformation was observed with this vector that
contained such large DNA inserts. Handling was also a problem because these large
DNA segments sheared with ease if processing was too rigorous, resulting in a loss of
some portion of the DNA insert (Sternberg, 1990). Both deletions and chimerism were
also found to be specifically related to mega-YAC clones.
Chimerism is a phenomenon in which segments of DNA from more than one
origin are cloned into the same vector. For instance, a chimeric YAC may contain
segments of genomic DNA from chromosomes 1 and 6. This problem has a tremendous
effect on gene mapping, because it is presumed that DNA cloned in a specific YAC
originates from only one source. A "mis-map" would be detrimental to the entire
mapping process. The term "mis-map" refers to a DNA sequence that is reported to
originate from one chromosome when it really originates from another. Similarly, with
deletions, if segments are arbitrarily missing from a DNA insert that is presumed to
contain an intact segment, an accurate sequence cannot be obtained. This could be
disastrous for all scientists who rely primarily on YACs for genome mapping.
When these problems were discovered, some genome scientists reverted to the
more reliable, smaller vectors. However, efforts were immediately made to correct the
existing problems with YACs. Firstly, to improve processing, a method was devised in
which the YACs were embedded in an agarose medium to prevent shearing of the DNA.
This method has been effective with up to 100% recovery of the DNA. Secondly,
chimerism was addressed by developing methods to detect chimeras. Fluorescence in
situ hybridization (FISH) is one such approach. In this method, Alu polymerase chain
reaction (PCR) was performed on a particular YAC. The Alu products are interspersed
repeat DNA sequences in the genome. The Alu-PCR products are fluorescently labeled
and used as probes on metaphase chromosomes from the source of the insert DNA (Trask
et al., 1991). An alternative method involves the hybridization of labeled Alu-PCR
products to a dot blot containing Alu-PCR products from each of the 24 human
chromosomes (Banfi et al., 1992). With these modifications, the efficacy of YACs has
been greatly improved.
2.2 EXON TRAPPING/AMPLIFICATION
While genome mapping was becoming a very popular area of research, most
scientists were interested in solely obtaining a map of the genome, without regard to the
complexity of the genome. An entire sequence map would be a great advancement in
human genetics, however, such a map would not distinguish the non-coding regions
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(introns) from the coding regions (exons) of the genome. It was, therefore, necessary to
develop a system that would allow for the isolation of exon sequences.
The exon amplification system was developed by Buckler et al. (1991). At that
time, existing methods were tedious, time-consuming, and inefficient. They included
CpG island based methods (Bird, 1986), sequencing large regions of genomic DNA and
assessing for open reading frames, direct DNA selection (Parimoo et al, 1991; Lovett et
al, 1991), direct screening (Wallace et al, 1990), and genomic sequencing.
In the original exon amplification procedure, cloned genomic DNA fragments are
placed in the pSPLl vector (Buckler et al, 1991). This vector contains an HIV tat intron
which is flanked on both the 5' and 3' positions by splice acceptor and donor sites,
respectively, as well as HIV tat exons. A multiple cloning site is present in the HIV tat
intron. When transfected into COS cell lines, pSPLl is transcribed through the SV40
viral origin of replication and early promoter. COS is an African green monkey kidney
cell line that the SV40 large T antigen which binds to the SV40 origin of replication
contained in the plasmid (Edwards and Aruffo, 1993). This action stimulates DNA
replication. After transcription occurs, total RNA is isolated from the cells and cDNA is
made via reverse transcription. The cDNA is then used in polymerase chain reaction
(PCR) and the amplified products are ligated into a cloning vector and transformed into
an E. coli strain. The transformants are screened via PCR for exogenous DNA inserts.
Based on the agarose gel analysis of the PCR products, candidate clones are selected for
sequencing.
Exon amplification, although a useful procedure for isolating transcribed
sequences, had one flaw in its system. Clones were obtained that appeared to be exon
sequences, but were in fact completely pSPLl vector sequences or splice artifacts which
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were amplified in the PCR reaction. In efforts to correct this problem, modifications to
the pSPLl vector were made, forming the pSPL3 vector (Church, et al., 1994) (Fig. 3).
In this vector, the HIV tat exon was altered by adding BstXI half sites to the 5' end of one
exon and the 3' end of the other (Fig. 3). When the tat exons are joined during splicing, a
functional restriction site is formed because exogenous DNA fragments do not interrupt
the HIV tat exons. Therefore, a restriction digestion with BstXI is done to remove all
artifacts that contain solely vector sequences.
Once the pSPL3 vector was used for exon amplification, it was observed that up
to 50% of the trapped exons contained a cryptic splice exon which was derived from the
intronic region of the pSPL3 vector (Burn et al, 1995). These spliced sequences called
artifacts resemble putatively trapped exons, and their identities are not disclosed until
after sequencing (Abel et al., 1994, North et al., 1993). Therefore, modifications were
made to the existing pSPL3 vector, forming the pSPL3B vector. The pSPL3B vector is
essentially identical to the pSPL3 vector, except that a 116 base pair nucleotide sequence
of the HIV tat intron was removed by restriction digestion. These modifications greatly
increased the efficiency with which exon sequences were obtained that did not contain
vector-derived sequences.
12









Figure 3. pSPL3 Exon Trapping Vector (Life Technologies).
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2.3 Bioinformatics
Once a transcript is obtained, it is necessary to characterize its sequence. For this
purpose, several sequence databases have been established. Of these, the GenBank
database is the most commonly used in the United States. GenBank is the database for
the National Institutes of Health, and contains a collection of sequences, which have been
deposited from public submissions (Benson et al., 1998). GenBank data are exchanged
with that of the European Molecular Biology Laboratory (EMBL) Data Library and the
DNA Data Bank of Japan (DDBJ). Information is exchanged between these three
organizations on a daily basis. This exchange allows widespread accessibility of the data
and transfer of information (Benson et al., 1998). As of December 1998, GenBank
contained approximately 3,044,000 records, which contained 2,162,000,000 bases. The
basic local alignment search tool (BLAST), developed by Altschul et al. (1990) uses an
algorithm which provides a rapid means for sequence comparison. BLAST allows for
comparison of sequences, regardless of size, and gives a statistical probability of the
sequence homology. The use of programs of this type allows the establishment of
novelty of an input sequence as well as the sequence similarity to other sequences of any
species in the database.
In this research, exon trapping was used to isolate transcribed sequences from
genomic DNA contained in mega-YAC clone 2001C6 which contained 1.7 MB of DNA
from human chromosome 17q21. Isolation of transcripts was confirmed by sequence
analyses using BLAST search and RNA dot blot analyses.
CHAPTER 3
MATERIALS AND METHODS
3.1 Isolation of mega-YAC Clone 2001C6
A yeast culture of S. cerevisiae, strain AB1380 containing a mega-YAC clone
2001C6, was obtained from CEPH/Genethon (Paris, France). This mega-YAC clone,
specifically, contains a 1.7 Mb genomic DNA insert from human chromosome 17q21,
which is cloned into the pYAC4 vector. A sample of the culture was inoculated onto
AHC plates (yeast nitrogen base without amino acids and without ammonium sulfate,
casein hydrolysate-acid (salt free, vitamin free), adenine hemisulfate, glucose,
ampicillin), and incubated at 30°C for 72 hours. A colony from the secondary culture
was then inoculated into 100 ml AHC media and incubated for 72 hours in a gyratory
incubator at 30°C.
3.2 Preparation of Spaghetti-type Plugs
The cells were harvested by centrifugation at 17,000 x g for 10 minutes in a
Beckman J2-21 centrifuge. The supernatant was discarded, and the cells were washed
two times with 50 mM EDTA. The cells were resuspended in 2 ml SCE (1M sorbitol,
0.1 M sodium citrate, 60 mM EDTA [final pH adjusted to 7 with HC1]). One hundred
fifty microliters of 1 M DTT (dithiothreitol) and 26 U lyticase (Yeast Lytic Enzyme,
Sigma Corp., St. Louis, MO) were added to the cell suspension to partially digest the cell
wall. The suspension was then incubated at 37°C for 5 minutes to allow for spheroplast
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formation. A spheroplast is a cell whose outer wall is partially intact or completely
absent. A 2% solution of In-Cert agarose (FMC Bioproducts, Rockland, ME) in SCE
was added to the spheroplasts. The solution was mixed and incubated in a 50°C water
bath for approximately 2 minutes. The mixture was then pipetted into 1 ml sterile
pipettes whose narrow tips were removed. The pipettes were then sealed with parafilm
and incubated at room temperature for 10 minutes, then at 4°C for 10 minutes. After
solidifying, the plugs were blown into a mixture of SCE containing 254 U lyticase
(Sigma, St. Louis, MO), and incubated at 37°C for 2.5 hours with rocking. The
SCE/lyticase mixture was then removed. In-gel lysis was then performed by replacing
the SCE/lyticase solution with lysis solution (0.45 M EDTA, pH 8, 10 mM Tris-HCl,
pH 8, 1% N-laurylsarcosine) containing lmg proteinase K /ml (Sigma, St. Louis, MO)
and incubating overnight in a 50 °C water bath. The lysis solution was removed and
replaced with 50 mM EDTA. The plugs were then placed on a rocker and incubated at
4°C. The 50 mM EDTA was replaced every three hours for 9 hours. After the final
wash, the EDTA was then replaced with fresh EDTA containing 0.5 |ig/ml RNAse A
(Sigma, St. Louis, MO) and the plugs were incubated at 37°C for 30 minutes in a water
bath. The EDTA/RNAse solution was removed and replaced with fresh 50 mM EDTA
and incubated on a rocker overnight at 4°C. The EDTA was removed and replaced with
fresh 50 mM EDTA and incubation with rocking was continued at 4°C for 1.5 hours.
This was repeated two times within 3 hours.
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3.3 Pulsed Field Gel Electrophoresis
3.3.1 Preparation of Gel
A 0.8% SeaKem Gold Agarose (FMC BioProducts, Rockland, ME) gel was made
in 0.5 X TAE (Tris, acetate, EDTA). The plug was placed on the gel comb, then into the
gel casting tray. The liquid gel solution was then poured into the gel casting tray and
allowed to solidify with the plug inside of it at room temperature.
3.3.2 Electrophoresis
The initial parameters for PFGE were: initial switch time (1ST): 40 sec. , final
switch time (FST): 60 sec, voltage: 3.9 v/cm, included angle: 106°, run time: 48 hrs.
The gel was run, stained with ethidium bromide (Sigma, St. Louis, MO) at 0.5 ng/ml and
viewed on a transilluminator. Because of the large size of the YAC (1.7 MB), it co-
migrates with the 1.6 MB Saccharomyces cerevisiae chromosome. Therefore, at these
parameters, the YAC could not be independently isolated from the 5. cerevisiae
chromosome IV. The PFGE parameters were optimized to 1ST: 60 sec, FST: 120 sec,
voltage: 6 v/cm, included angle: 120°, run time: 24 hrs. At these parameters, the YAC
was clearly isolated independently of the yeast chromosomes. A DNA size standard for
5. cerevisiae was simultaneously electrophoresed with the YAC. This standard only
contains the 16 natural 5. cerevisiae chromosomes.
After electrophoresis, the portion of the gel containing the size standard was cut
and stained with ethidium bromide. The location of the YAC on the gel was determined
by comparison with the yeast standard. A band being present in the lanes where the
spaghetti-type plug was placed, but absent in the lane where the size standard was placed
identified the location of the YAC.
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Once the location of the YAC was identified, the distance of migration of the
YAC was measured. Then, the unstained portion of the gel was aligned with the stained
portion, and the YAC was excised from the unstained portion of the gel.
3.4 Southern Hybridization of YAC
The stained portion of the gel was blotted and probed with radiolabeled pBR322
to further confirm the presence of the YAC. pBR322 is the parent vector of the pYAC
series of cloning vectors. pBR322 was labeled using a random primed labeling method.
The random primed method of labeling uses a double stranded template that is denatured.
Random oligonucleotide hexamers then anneal to the single strands of the template, and a
new strand of DNA is synthesized in the 5'—3' direction by the Klenow fragment of
E. coli polymerase I (Feinberg and Vogelstein, 1983).
3.5 In-Gel Restriction
The agarose containing the YAC was cut into small pieces. The gel slices were
then weighed and placed into a conical tube in preparation for restriction digestion.
Restriction buffer, React 2 (50 mM Tris-HCl, 10 mM MgCl2, 50 mM NaCl) (GibcoBRL,
Gaithersburg, MD) was then prepared at IX concentration. React 2 restriction buffer
corresponds to the BamHI and BgUI restriction enzymes. The gel slices were equilibrated
in the IX restriction buffer by incubation on ice for 30 minutes. The restriction buffer
was removed and replaced with fresh IX buffer. A double digestion using BamHI and
BgUI was performed on the gel slices with 150 U of each enzyme. The enzyme was
added to the gel slices and digestion proceeded at 37°C overnight.
3.6 Gel Extraction
The restricted YAC DNA was extracted from the agarose using the QIAEX II
Gel Extraction Kit (QIAGEN, Chatsworth, CA). In this process, the agarose is
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solubilized by a buffer that contains high chaotropic salts, which allows binding of the
nucleic acids to silica gel particles. The salts are then removed by ethanol washing and
the nucleic acids are eluted from the silica particles with a low salt buffer. The extracted
DNA was quantified using GENEQUANT II (Pharmacia Biotech Inc., Piscataway, NJ)
by 260/280nm UV light.
3.7 Exon Trapping
3.7.1 Ligation and Transformation
The DNA obtained from the gel extraction was ligated into the exon trapping
vector pSPL3 using T4 DNA ligase in a 20 jllI reaction mix containing 0.5 \ig digested
DNA, 150 U T4 DNA ligase (GibcoBRL), 50 ng BamHI cut pSPL3 and IX ligase buffer
[250mM Tris-HCl (pH 7.6), 50 mM MgCl2, 5 mM ATP, 5 mM DTT, 25% (w/v)
polyethylene glycol-8000] (GibcoBRL, Gaithersburg, MD). The pSPL3 vector was
restricted with BamHI before ligation. BamHI is the same as the restriction enzyme used
for digestion of the genomic DNA.
Transformation was performed by a standard heat shock protocol using High
Efficiency HB101 competent cells (Promega, Madison, WI). The HB101 (E. coli strain)
cells were thawed on ice. Fifty nanograms of the cloned DNA were added to 100 |xl
competent cells in a microcentrifuge tube. The tubes were immediately placed on ice and
incubated for 10 min. The cells were heat shocked for 45 seconds at 42°C , immediately
placed on ice and incubated for 2 min. Next, 900 |xl SOC media [Bacto-Tryptone, Bacto-
Yeast Extract, 1M NaCl, 1M KC1, 2M Mg" (1M MgCl2 • 6H2O, 1M MgSO4 • 7H2O), 2M
glucose] were added to the cells. The mixture was then incubated at 37°C with shaking
at 225 rpm for 1 hr. The transformation reaction was then plated onto Luria Broth
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(LB)/agar plates [tryptone, yeast extract NaCl, NaOH, 15 g Bactoagar/L (DIFCO)]
containing 50 jug ampicillin /ml and incubated at 37°C overnight. Ten milliliters of
sterile LB were then added to each plate and the transformants were scraped off the
surface of the agar with a sterile loop. The cells were then pipetted into a centrifuge tube
and harvested by centrifugation. The supernatant was discarded. The cells were then
resuspended in SOC media and centrifuged. The supernatant was again discarded. The
cells were resuspended in sterile PBS (137 mM NaCl, 2.7 mM KC1, 4.3 mM NajHPO, •
7H2O, 1.4 mM KH2PO4). The cells were harvested by centrifugation and the supernatant
was discarded.
3.7.2 Plasmid Purification
Plasmid purification was performed using the QIAwell 8 Plasmid Purification Kit
(QIAGEN, Chatsworth, CA). This system employs alkaline lysis to release cell contents,
then vacuum filtration through a filter that contains anion-exchange resin. The
manufacturer does not provide specifications of the resin. The resin binds DNA, which is
then eluted with a low salt buffer. The DNA was quantified using the GENEQUANT II
(Pharmacia Biotech, Piscataway, NJ) spectrophotometer.
3.7.3 Transfection into Cos-7 Cells
Transfection was performed using the LipofectAce reagent (GibcoBRL). This is a lipid-
mediated transfection in which the plasmid DNA is encapsulated in a lipid membrane.
The liposomes then fuse with the membrane of mammalian cells of interest. Three
microliters of LipofectACE reagent was added to 100 \i\ Opti-MEMI medium without
serum (GibcoBRL) in a sterile microcentrifuge tube. Opti-MEMI medium is a non-
serum medium for mammalian cells. This particular medium is preferred because of its
low lipid content. This increases the effectiveness of the lipid-mediated transfection.
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The components were gently mixed and incubated at room temperature for 5 minutes.
One microgram of DNA was added to 100 (Xl of OPTI-MEMI media in a separate
microcentrifuge tube. A control sample was used without DNA. The
LipofectACE/OPTI-MEMI mixture and the DNA/OPTI-MEMI mixture were combined,
gently mixed and incubated at room temperature for 10 minutes.
Cos-7 cells were cultured to 80% confluence in 6-well plates. Supplemented D-
MEM (10% Fetal Bovine Serum (FBS), IX antibiotic/antimycotic solution [10,000U
penicillin, lOmg streptomycin, 25 (ig amphotericinB, 0.9% sodium chloride]) (Sigma, St.
Louis, MO) was removed from the cells. Two milliliters of Opti-MEMI medium
(GibcoBRL, Gaithersburg, MD) were added to each well. The cells were incubated at
37°C for 13 minutes. Next, 0.8 ml of Opti-MEMI medium was added to each
DNA/lipid/Opti-MEMI mixture. The Opti-MEMI was removed from the wells and the
DNA/lipid/Opti-MEMI mixture was added to each well. The plates were then incubated
overnight at 37°C in a 5% CO2 incubator. The DNA/lipid/Opti-MEMI mixture was then
removed from the wells, replaced by 3 ml of supplemented D-MEM and incubated for
24 hrs at 37°C in a 5% CO2 incubator. Controls for this experiment included using a lipid
complex that contained no DNA and a well containing only Opti-MEMI medium.
3.7.4 RNA Isolation
Total RNA was isolated using the TRIzol reagent (GibcoBRL, Gaithersburg,
MD). The TRIzol method of RNA isolation is a one-step method using a monophasic
solution of phenol and guanindine isothiocyanate. TRIzol disrupts the cell membrane
and dissolves the cellular components while maintaining the integrity of the RNA
(Chomczynski and Sacchi, 1987; Chomczynski, 1993).
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The media was removed from each well. One milliliter of TRIzol reagent was
added to each well and mixed with a sterile pipette to release the cells from the surface of
the wells. The mixture was then transferred to a sterile microcentrifuge tube and
incubated at room temperature for 5 minutes. Two hundred microliters of chloroform
were added to each tube. The tubes were then vortexed, incubated at room temperature
for 3 minutes and centrifuged at 12,000 x g for 15 minutes at 4°C. The upper aqueous
layer was transferred to a sterile tube. Then, 500 ^.1 isopropanol were added to each tube.
The tubes were mixed by inversion and incubated at room temperature for 10 minutes.
The tubes were then centrifuged again at 12,000 x g for 10 minutes at 4°C. The
supernatant was removed and discarded. Next, 1 ml of 75% ethanol was added to each
tube. The contents of the tubes were mixed and centrifuged at 7,500 x g for 5 minutes at
4°C. The supernatant was removed and discarded. The pellets were air-dried. The RNA
pellets were then dissolved in 50 \i\ sterile diethylpyrocarbonate (DEPC)-treated double
distilled water (ddH20), incubated at 65°C for 5 minutes and vortexed. DEPC treatment
followed by sterilization denatures and destroys most RNAses, thereby making solutions
RNAse-free.
3.7.5 cDNA Synthesis
Reverse transcription was performed using 3 |LLl of total RNA previously isolated
from transfected Cos-7 cells, 2.5 |il 10X PCR Buffer, 4 \i\ 10 raM dNTPs, 0.1 M
Dithiothreitol (DTT), 1.25 |xl SA2 primer (see Table 1), DEPC-treated H2O, 1 ul RNasin
(diluted 1:10 in DEPC-treated H2O), and 200 U Moloney Murine Leukemia Virus
Reverse Transcriptase (MMLV-RT). RNAsin is an RNAse inhibitor isolated from
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placenta. The reverse transcriptase reaction was incubated at 42°C for 90 minutes in a
Temp«Tronic thermal cycler (Barnstead/Thermolyne, Dubuque, IA).















The cDNA was made double stranded by PCR using the entire reverse
transcriptase reaction. A 100 jxl system includes RT reaction, 7.5 (il 10X PCR Buffer,
12 ^11.25 mM dNTPs, 3.75 ul SA2 (20 \iM) (see Table 1), 5 jil SD6 (20 \iM)
(see Table 1), H2O, and 0.5 \x\ Taq DNA polymerase containing 5 U/\iX (Perkin-Elmer,
Almeda, CA). PCR was performed at [94°C 1 min, 60°C 1 min, 72°C 5 min] x 6 cycles
on the GeneAmp PCR System 2400 (Perkin-Elmer, Almeda, CA). The PCR products
were digested overnight with 50 U BstXI at 55°C in a water bath. Spike digestion was
done by adding 10 U of BstXI to the digest and incubating for 1.5 hrs at 60°C in a water
bath. Digestion with BstXI eliminates PCR products resulting from vector-vector
splicing.
3.7.7 Secondary PCR
The double stranded DNA was amplified by PCR in the following reaction
mixture: lOjxl digested 1°PCR, 10X PCR Buffer (100 mM Tris-HCl ; pH 8.3, 500 mM
KC1, 15 mM MgCl2, 14.4 ^1 1.25 mM dNTPs, 3.75 yl dUSA4 (20 ^M) (see Table 1), 5
M-l dUSD2 (20 uM) (see Table 1), H2O, 0.5 |xl Taq polymerase containing 5U/^il (Perkin-
Elmer, Almeda, CA). PCR was performed at [94°C 1 min, 60°C 1 min, 72°C 3 min] x 25
cycles. Cycling was performed in the GeneAmp PCR System 9600 (Perkin-Elmer,
Almeda, CA).
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3.7.8 Uracil DNA Glycosj lase (UDG) Cloning
The secondary PCR products were cloned into the pAMPl vector (GibcoBRL,
Gaithersburg, MD) using 5 jLil 2° PCR reaction, 13 jil UDG Annealing buffer (10 mM
Tris-HCl pH 8.4, 50 mM KC1, 1.5 mM MgCl2), 1 \i\ pAMPl DNA, and 1 U UDG
Enzyme. The reaction was incubated at 37°C for 30 minutes in GeneAmp PCR System
2400 thermal cycler (Perkin-Elmer, Almeda, CA). UDG-cloning is a necessary
component of this process because the primers used to amplify the PCR products
incorporate uracil residues into the DNA. Treatment with UDG removes the uracil
residues from the DNA fragments (see figure 4). This method is used because it creates
overhangs for cohesive end ligation into the pAMPl vector.
Transformation was performed using 20 |xl of the UDG Cloning reaction mixture.
Then, 50 |0.1 of 50 \iM CaCl2 and 60 |xl DH5a cells were added. The cells were heat
shocked at 42°C for 1 minute and immediately placed on ice. Next, 1 ml SOC media was
added, and the cells were incubated at 37°C for 1 hr with shaking at 225 rpm. The cells
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Figure 4. UDG Cloning. As the DNA inserts are cloned into pAMP1, Uracil
DNA Glycosylace removes the uracil residues (Rashtchian, 1995).
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Figure 4. UDG cloning (GIBCO BRL). As the DNA inserts are cloned into pAMPl,
Uracil DNA Glycosylase removes the uracil residues (Rashtchian, 1995).
3.7.9 Colony PCR
Luria Broth containing 50 jig ampicillin/ml was added to each well of sterile 96-
well plate. One colony of the transformants was then added to each well of the plates and
incubated at 37°C overnight. Fifty microliters of ultrapure Glycerol (Sigma, St. Louis,
MO) were then added to each well of the plates. The plates were then stored at -70°C.
Colony PCR was performed using 2 |llI DNA, 5 jllI 10X PCR Buffer, 0.5 u.1 each
SA5 and SD5 (see Table 1), 0.3 Taq Polymerase containing 5 U/ul (Perkin-Elmer,
Almeda, CA), H2O in a 50 |il system. PCR conditions were [94°C, 1 min., 60°C, 1 min.,
72°C, 3 min.,] x 25 cycles. The GeneAmp PCR System 9600 (Perkin-Elmer, Almeda,
CA) was used.
3.8 Selection of Trapped Exons
The PCR products were electrophoresed in 2.5% LMP (low melting point)
agarose gels in 0.5X TBE and stained with ethidium bromide at 0.5 (ig/ml. Those
samples that produced distinct amplification patterns were identified as clones containing
putatively trapped exons and were selected for sequencing.
3.9 Cycle Sequencing
Ten clones were selected for sequencing. They were A5, C5, D4, E5, El 1, E12,
F12, G12, H4, and HI 1. Ten microliters of each sample were inoculated into 15 ml LB
containing 50 |ig ampicillin/ml and incubated overnight at 37°C with shaking at 225 rpm.
Plasmid purification was performed using the QIAGEN Plasmid Purification System
(QIAGEN, Chatsworth, CA) as described in section 3.7.2. Cycle Sequencing was
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performed using the Perkin-Elmer Dideoxy Dye-Terminator Sequencing Kit. The
reactions were performed using 1 p.g DNA template, 8 \i\ Dye-terminator mix,
100 ng primer/|il, and ddH2O (sterile). Each sample was sequenced using T7, SP6, M13
Forward, and M13 Reverse primers (see Table 1). Cycling parameters were: 94°C 1
min, [96°C 30 sec, 48°C 15 sec, 65°C 4 min.] x 25 cycles. Cycle sequencing was
performed on the GeneAmp PCR Systems 2400 and 9700 (Perkin-Elmer, Almeda, CA).
Sequencing was performed in the Molecular Biology Research Laboratory (MBRL) at
Clark Atlanta University.
3.10 Data Analyses
Once the sequences were obtained, each sequence was analyzed using the Basic
Local Alignment Search Tool (BLAST) which is available on the internet from the
National Library of Medicine's National Center for Biotechnology Information (a
division of the National Institutes of Health). These analyses were performed to assess for
the novelty or homology of each sequence. Any sequence that had significant homology
to other sequences published in the database was noted for their similarity. The
sequences that showed no significant similarity to the sequences in the database were
selected for assessment of their expression patterns.
3.11 Assessment for Expression
3.11.1 Plasmid Purification
The clones whose sequences had no significant homology to any sequence in the
database were selected from the glycerol stocks at -70°C. Ten microliters of each sample
were inoculated into 5 ml LB containing 100 )xg ampicillin/ml and grown overnight at
37°C with shaking at 225 rpm. The culture was then inoculated into 500 ml LB
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containing 100 (Xg ampicillin/ml and grown overnight at 37°C with shaking at 225 rpm.
The plasmids were purified using the QIAGEN Plasmid Purification System.
3.11.2 Preparation for Probe Labeling
In preparation for RNA dot blot analysis, each clone that was to be used as a
probe was amplified by PCR using unlabeled dNTPs. Two different primer sets were
used. SP6 and T7 (Promega Corp., Madison, WI) were used in one set, and Ml3
Forward and Ml3 Reverse (Promega Corp., Madison, WI) were used in the other set
(Table 1).
3.11.3 Labeling of Probes
All probes were labeled by PCR using 200 ng plasmid DNA, 2.25 pmol each T7
and SP6 primers, 1.25 mM each of unlabeled dATP, dTTP, and dGTP, 6.25 U Taq DNA
polymerase, and 50 ^.Ci 32P-a-dCTP (Amersham, Arlington Heights, IL). Cycling
conditions were 94°C-1 min, [94°C-1 min., 45°C-1 min., 72°C-1 min.] x 25 cycles, 72°C-
T, 4°C°° . After PCR, a 1 |xl sample was taken from each reaction and placed on a glass
filter. Each reaction was then passed through a Centri-sep column (Princeton
Separations, Princeton, NJ) to remove unbound nucleotides. Centri-sep columns are
based on size exclusion, and allow rescue of DNA molecules greater than 16 base pairs.
A 1|ll1 sample was then taken from each reaction and placed on a glass filter. The glass
filters were then placed in scintillation vials. Liquid scintillation fluid was placed in each
vial and the activity of the probes was measured in a Beckman Scintillation Counter
Model LS5000TA in the Molecular Biology Research Laboratory at Clark Atlanta
University.
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3.11.4 Dot Blot Analyses
A Human RNA Master Blot was purchased from Clonetech (Palo Alto, CA).
This blot contains 50 different human poly A+RNAs (see Fig. 13, Table 2). The blot was
placed into a hybridization bottle. Five milliliters of ExpressHyb hybridization solution
(Clontech, Palo Alto, CA) were added to the bottle. The membrane was equilibrated at
60°C for 1 hr. The radiolabeled probe was denatured at 100°C for 10 min and
immediately added to the hybridization solution and incubated overnight in a
hybridization oven rotating at 60°C. The membrane was then washed two times at room
temperature with 25 ml post hybridization wash solution 1 (2X SSC, 0.1% SDS) for
15 min. Then, the membrane was washed two times with 25 ml post hybridization wash
solution 2 (0.2X SSC, 0.1% SDS) at 42°C for 15 min. The membrane was then wrapped
in plastic wrap, and placed in an autoradiograph cassette with X-Ray film between two
intensifying screens. The cassette was then placed in the freezer at -70°C overnight. The
autoradiograph was then developed in a Kodak X-Ray processor, and the hybridization
signals were observed on a light box. The membrane was then stripped by boiling in
0.5% SDS on a hot plate for 10 minutes, then removing the solution from the hot plate
and allowing the solution with the membrane in it to cool for 10 minutes. The membrane
was then assessed for the presence of radioactivity with a survey meter, wrapped in
plastic wrap, and stored at -20°C until the next hybridization reaction.
The manufacturer normalized the RNAs on the Human RNA Master Blot
(Clonetech Laboratories, Palo Alto, CA) to eight housekeeping genes. This
normalization ensures an equalized intensity after hybridization relative to the amount of
RNA loaded for each tissue. The human ubiquitin control was labeled using the Prime-
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A-Gene Labeling System (Promega Corp, Madison, WI). The Prime-A-Gene system is a
random primed method for labeling. The labeling reaction contained IX labeling Buffer
(50 mM Tris-HCl-pH 8.0, 5 mM MgCl2,2 mM DTT, 0.2 M HEPES-pH 6.6, 5.2
A26O U/ml random hexadeoxyribonucleotides), 20 \iM each unlabeled dATP, dGTP, and
dTTP, 500 ng denatured ubiquitin DNA/ml, 400 [ig Nuclease-Free BSA/ml, 50 jnCi ot-
32P-dCTP/ml, and 5 U DNA Polymerase I Large Klenow Fragment. The reaction was
incubated at room temperature for 60 minutes. The reaction was terminated by heating at
100°C for 2 minutes and immediately chilled in an ice bath. EDTA was then added to
the reaction at 20 mM and the reaction was used for hybridization using the conditions
for the previous hybridization reactions. This procedure was repeated for each probe.
CHAPTER 4
RESULTS
4.1 Isolation of Mega-YAC Clone 2001C6
After several rounds of PFGE, the electrophoresis parameters were optimized to
independently separate the mega-YAC. Although the original size of the YAC is 1.7
MB, after PFGE, the YAC actually measures approximately 1.5 MB. This size decrease
is attributed to the increased possibility of shearing of the high molecular weight DNA or
to lack of resolution of the agarose gel. The shearing is evident by the smear that is
observed in the photograph (Fig. 5 (left)). The presence of the YAC was confirmed by
Southern hybridization using 32P-ot-dCTP labeled pBR322 DNA.
4.2 Selection of Candidate Exons
Candidate exons were selected on the premise that a distinct amplification pattern
was observed, and that the amplified band was distinguishable from the baseline. The
baseline is the result of primer dimer or free primer in the agarose gel. The white arrows
in Figure 6 indicate the ten clones containing the candidate exons. Of the ten clones, C5,
F12, G12 had no significant homology to sequences in the database (see Table 2).
Clones A5, C5, D4, El2, H4, Ell and Hll were eliminated as potential exons based on




Figure 5. Isolation of Mega-YAC Clone 2001C6. Pulsed field gel of Mega-YAC clone
2001C6 (left). Roman numerals represent the respective S. cerevisiae
chromosomes. On right, autoradiograph of blotted pulsed field gel on left
probed with pBR322 DNA. Arrow on right represents hybridization signal
which indicates the location of the YAC.
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Figure 6a. Selection of Candidate Exons
Figure 6b. Selection of Candidate Exons
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PCR amplification of the three candidate exons using the combination of T7/SP6
and M13-forward and reverse primers all indicate that the inserts were amplified.
However, with the T7/SP6 combination, the intensity of amplification was higher than
that of the M13-forward and reverse combination (Fig. 7). As a result of this
experimentation, the T7 and SP6 primers were used for the radiolabelling experiment.






























Figure 7. PCR Amplification of Potentially Trapped Exons
Lanes 1 and 10-100 bp ladder (Promega Corp., Madison, WI)
Lane 2- E5-M13F/M13R Lane 6-E5-SP6/T7
Lane 3-F12-M13F/M13R Lane 7-F12-SP6/T7
Lane 4 -G12-M13F/M13R Lane 8-G12-SP6/T7
Lane 5-No DNA-M13F/M13R Lane 9-No DNA-SP6/T7
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4.3 Northern Hybridization
Hybridization of clone G12 with the RNA Master blot (Fig. 8) indicates that the
cloned fragment hybridized to all of the RNAs on the blot (Figures 8 and 9). The clone
did not hybridize to any of the yeast controls or the E. coli RNA (Fig. 8). However,
hybridization was observed with E. coli DNA.
Hybridization of clone F12 indicates that expression is found in bone marrow,
fetal liver, fetal spleen, and placenta mRNAs (Figures 8 and 10). No hybridization was
observed with the yeast controls or the E. coli RNA. However, hybridization was
observed with E. coli DNA.
Hybridization of clone E5 indicates that expression is found in fetal liver,
placenta, and a small level of expression in fetal spleen and fetal kidney (Figures 8
and 11). No hybridization was observed with the yeast controls or the E. coli RNA.
However, hybridization was observed with E. coli DNA.
Hybridization with human ubiquitin probe indicated relative levels of RNA in
each dot (Figure 11). No hybridization was observed in yeast or E. coli DNA



















































































































Figure 9. RNA Master Blot probed with Radiolabeled clone G12
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Figure 11. RNA Master Blot probed with Radiolabeled clone E5
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Figure 12. RNA Dot Blot probed with Radiolabeled Human Ubiquitin
Control cDNA.
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Table 3. Tissue Sources of mRNAs on Human RNA Master Blot (Clontech
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CHAPTER 5
DISCUSSION AND CONCLUSIONS
After successive PFGE, the optimal conditions were determined for isolation of
the mega-YAC clone 2001C6. The results of pulsed field gel electrophoresis indicate
that the YAC is approximately 1.5 megabases in size. The fragments resulting from
shearing are usually approximately 23 kb in size. Shearing did not significantly effect the
restriction of the YAC.
The exon trapping technique was used because of its ability to extract exons out
of large fragments of genomic DNA. Though this technique produces some artifacts, it is
still one of the most direct methods for determining exons and gene sequences within
genomic DNA. Although exon trapping is a very useful technique for isolating
transcribed sequences, several inherent problems exist with the present exon trapping
protocol, and were previously discussed. Despite these potential problems, ten putative
exons were isolated using the current exon trapping protocol. Of the ten trapped exons,
three contain putatively novel sequences. This rate is consistent with that reported by
Pribilletal. (1997).
In recent exon trapping experiments, Warneke-Wittstock et al. (1998) established
several guidelines for putatively trapped exon sequences to be considered transcription
units. These guidelines include: 1) the trapped exon must be flanked by consensus splice
site sequences, 2) the putative exons must show significant homology to the dbEST
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and/or protein databases, and/or 3) the transcription units must produce a hybridization
signal in Northern blot analysis (Warneki-Wittstock et ai, 1998). Dahmane et al. (1998)
reported that transcription units must meet one of the following criteria. The
transcription units must: 1) produce significant similarity to nucleotide or predicted
amino acid sequences from the databases; 2) contain both cDNA(s) and trapped exon(s);
or 3) produce and RNA transcript detected on Northern blots (Dahmane et al, 1998).
Based on the criteria established in the literature, it was confirmed that the putatively
novel transcripts were isolated in the exon trapping experiments reported in this thesis.
Data analyses using the GenBank database indicated that seven of the ten putative
trapped exons showed significant homology to previously published sequences in the
database. These sequence homologies were to HIV tat, (3-globin, and pSPL3 vector.
The three sequences that showed no homology to the sequences in the database were
further analyzed for expression using the Human RNA Master Blot (Clonetech, Palo
Alto, CA), and produced hybridization signals in one or more human mRNAs.
Each of the three clones selected for RNA dot blot analysis gave a different
expression profile. The results also indicate that the sequences in clones E5 and F12 may
be developmental^ regulated because they produce hybridization signals in placenta,
fetal liver, fetal spleen and fetal kidney, but hybridization is not detected in the adult
counterparts of the fetal tissues. In addition to the fetal tissues, clone G12 produced a
hybridization signal in bone marrow. Bone marrow is a differentiating tissue, which is a
further indication that this clone may have a role in developmental regulation.
Hybridization to E. coli DNA was also observed with each of the three clones.
This particular data can be perplexing, however this hybridization may be the result of
several phenomena. Firstly, and most probable is the fact that the DNA used to make the
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probes is cloned DNA. The plasmids in which the DNA is cloned are derived from E.
coli. Although the inserts alone were amplified by PCR, vector sequences still remain in
the amplified fragments. Secondly, since these plasmids are propagated in, it is possible
that E. coli genomic DNA may have contaminated the plasmid DNA during plasmid
purification. Because of the use of commercially available plasmid preparation kits, it is
highly unlikely that E. coli genomic DNA contamination is the culprit. However, this
possibility must still be considered. This phenomenon has been observed in previous
experiments (Her et al., 1997). In other experiments, the signal detected in E. coli
genomic DNA have either been dismissed as an artifact, because only human DNAs were
labeled as probes (Her et al., 1997), or the signal has not been addressed at all.
The main goal of this research project was to isolate transcribed sequences from a
1.7 MB region of human chromosome 17q21. The ultimate goal of the Human Genome
Project is to characterize all genes to the level of the nucleotide bases. The first step of
this process is to identify coding regions from non-coding regions of the genome, and to
separate them. Many genome scientists are assembling transcript maps by first
identifying small transcripts and placing them on a larger map using techniques such as
exon trapping.
The small transcripts are extended by several methods. RACE which is 5'- or
3'- rapid amplification of cDNA ends (Borson et ah, 1992, Frohman et al., 1988,
Uematsu, 1991) is a popular method which is widely used. The RACE technique allows
scientists to use small DNA fragments to design primers to obtain a larger fragment. The
larger fragments are then used to screen a cDNA library and obtain the full length of the
transcript. The full-length cDNA is then used to screen a sub-genomic YAC library. The
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isolated product from the genomic screen would then be sequenced to obtain the entire
sequence of the gene.
In addition, since mega-YAC clone 2001C6 is such a large clone, future research
would also include localization of the gene on the YAC. This localization would identify
the exact location of the gene on the chromosome.
The novel transcripts isolated from these experiments significantly contribute to
an enhanced high resolution map of human chromosome 17q21. The extension of this
research leads to gene identification, localization and ultimately gene discovery and
possibly gene therapy.
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